NONMEM Users Network Archive

Hosted by Cognigen

Mango Solutions Enterprise Applications of the R Language (EARL) conference- San Francisco June 2017

From: Christina Halliday <challiday>
Date: Wed, 26 Apr 2017 09:20:33 +0000

Hi Everyone,
Presentations from Pfizer, Amgen and Genentech have been selected and annou=
nced for our San Francisco Enterprise Applications of the R Language (EARL)=
 conference in June.
First held in 2014, the Enterprise Applications of the R Language Conferenc=
e is a cross-sector conference focusing on the commercial use of the R prog=
ramming language. The conference encompasses a range of workshops, two full=
 days dedicated to the real-world usage of R with the world's leading pract=
itioners, and a social program that offers an opportunity to network and en=
joy the local area.
During EARL, you'll have the opportunity to meet other R users from around =
the world and speak with some incredible companies that support R and data =
science. The EARL Conference is open to anyone with an interest in Data Sci=
ence and R
We will also be announcing speakers for London EARL shortly and will be cal=
ling for abstracts for Boston EARL in the Fall.
Details of the conference can be found at<http://w=>

For more information / conference promo codes please contact us via pharma<mailto:pharma

Academic and Commercial rates available.

Kind regards



This message is intended for the use of the named recipient(s) only and may=
confidential and / or privileged information. If you are not the intended r=
ecipient, please
contact the sender and delete this message. Any unauthorised use of the inf=
contained in this message is prohibited.

Mango Business Solutions Limited is registered in England under No. 4560258=
 with its
registered office at Suite 3, Middlesex House, Rutherford Close, Stevenage,=
 Herts, SG1 2EF,


Received on Wed Apr 26 2017 - 05:20:33 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: